1. Home
  2. QRVO vs DVA Comparison

QRVO vs DVA Comparison

Compare QRVO & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QRVO
  • DVA
  • Stock Information
  • Founded
  • QRVO 1957
  • DVA 1994
  • Country
  • QRVO United States
  • DVA United States
  • Employees
  • QRVO N/A
  • DVA N/A
  • Industry
  • QRVO Semiconductors
  • DVA Misc Health and Biotechnology Services
  • Sector
  • QRVO Technology
  • DVA Health Care
  • Exchange
  • QRVO Nasdaq
  • DVA Nasdaq
  • Market Cap
  • QRVO 8.3B
  • DVA 9.4B
  • IPO Year
  • QRVO 1997
  • DVA 1995
  • Fundamental
  • Price
  • QRVO $84.46
  • DVA $121.62
  • Analyst Decision
  • QRVO Hold
  • DVA Hold
  • Analyst Count
  • QRVO 14
  • DVA 4
  • Target Price
  • QRVO $98.23
  • DVA $145.00
  • AVG Volume (30 Days)
  • QRVO 1.9M
  • DVA 1.2M
  • Earning Date
  • QRVO 11-03-2025
  • DVA 10-29-2025
  • Dividend Yield
  • QRVO N/A
  • DVA N/A
  • EPS Growth
  • QRVO N/A
  • DVA 5.63
  • EPS
  • QRVO 2.30
  • DVA 9.76
  • Revenue
  • QRVO $3,663,072,000.00
  • DVA $13,317,965,000.00
  • Revenue This Year
  • QRVO $2.88
  • DVA $6.24
  • Revenue Next Year
  • QRVO $3.92
  • DVA $3.32
  • P/E Ratio
  • QRVO $36.75
  • DVA $12.43
  • Revenue Growth
  • QRVO N/A
  • DVA 5.14
  • 52 Week Low
  • QRVO $49.46
  • DVA $113.97
  • 52 Week High
  • QRVO $106.30
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • QRVO 45.93
  • DVA 49.01
  • Support Level
  • QRVO $78.70
  • DVA $113.97
  • Resistance Level
  • QRVO $82.78
  • DVA $122.26
  • Average True Range (ATR)
  • QRVO 2.44
  • DVA 3.08
  • MACD
  • QRVO -0.26
  • DVA 0.28
  • Stochastic Oscillator
  • QRVO 48.94
  • DVA 64.82

About QRVO Qorvo Inc.

Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: